Quality of life and congenital heart defects: comparing parent and professional values

Knowles, Rachel I.; Griebsch, Ingolf; Bull, Catherine; Brown, Jacqueline; Wren, Christopher; Dezateux, Carol
May 2007
Archives of Disease in Childhood;May2007, Vol. 92 Issue 5, p388
Academic Journal
Objective: To compare preferences obtained from health professionals with those from parents for the longer-term health outcomes of children with congenital heart defects. Setting: Cardiology conference; hospital. Participants: 109 paediatric cardiology professionals (72% female, median age 38 years) and 106 parents of children with congenital heart defects (82% female, median age 37 years). Interventions: Eight health state descriptions, for cardiac and neurological disability resulting from congenital heart defects, were developed and presented with a self-administered anonymous questionnaire. Respondents were asked to rank health state descriptions from best to worst, score each health state using a visual analog scale and mark death on this scale. Results: Health professionals and parents agreed in the order of ranking health states from best to worst. Both groups assigned the lowest scores to health states with severe neurological disability. Scores did not differ significantly by age, sex or whether the respondent was in the health professional or parent group. Of all respondents, 8% (17) scored at least one health state description worse than death. Conclusions: Parents and health professionals place similar values on the quality of life outcomes of children with congenital heart defects. Both are more averse to health states describing worse neurological than cardiac disability. Improving our understanding of the relative importance of different outcomes to children and families is an important basis for sharing decisions about clinical care. The views of young people with congenital heart defects should be an important focus for future enquiry into health outcomes.


Related Articles

  • Optimising palivizumab use in infants with heart disorders.  // PharmacoEconomics & Outcomes News;6/30/2007, Issue 531, p9 

    The article focuses on a study that examined the optimization of the use of palivizumab to treat infants with congenital heart disorders. According to Canadian researchers, the use of the drug can be optimized if infants requiring prophylaxis are prospectively identified and reviewed by...

  • Beyond survival: What are the outcomes that really matter to our patients? Mussato, Kathleen A. // Cardiology in the Young;Apr2006, Vol. 16 Issue 2, p125 

    The article discusses the importance of examining quality of life as an outcome for children with congenital cardiac disease. The article considers the issue of how to measure quality of life accurately and how to make sense of the findings obtained. According to the author, it is the values and...

  • The development of a new measure of quality of life for children with congenital cardiac disease. Macran, Susan; Birks, Yvonne; Parsons, Jonathan; Sloper, Patricia; Hardman, Geoff; Kind, Paul; van Doorn, Carin; Thompson, David; Lewin, Robert // Cardiology in the Young;Apr2006, Vol. 16 Issue 2, p165 

    The purpose of the study was to develop a questionnaire measuring health-related R1 quality of life for children and adolescents with congenital heart disease, the ConQol, that would have both clinical and research applications. We describe here the process of construction of a questionnaire,...

  • Factors affecting the quality of life in children with congenital heart disease. Nousi, Dionysia; Christou, Apostolos // Health Science Journal;2010, Vol. 4 Issue 2, p94 

    Congenital heart diseases are the second leading cause of death in infancy and childhood, as well as the only cause of heart disease in the pediatric population in the developing countries. Aim : The aim of the present study was to review the literature about factors that affect the quality of...

  • Quality of life following paediatric heart transplant: are age and activity level factors? Parent, John J.; Sterrett, Lauren; Caldwell, Randall; Darragh, Robert; Schamberger, Marcus; Murphy, Debbie; Ebenroth, Eric // Cardiology in the Young;Mar2015, Vol. 25 Issue 3, p476 

    Background: We evaluated whether quality of life correlates to age and activity in children following heart transplantation. In addition, quality of life in children following heart transplantation was compared with previously reported values in children with congenital heart disease. Quality of...

  • Quality of life in families of children with congenital heart disease. Goldbeck, Lutz; Melches, Juliane // Quality of Life Research;Oct2005, Vol. 14 Issue 8, p1915 

    Within a family perspective on quality of life (QL) with congenital heart disease, the study investigates parental QL, and patients' health-related QL as reported by themselves and by their parents. We examined the hypotheses that parental QL moderates the parental proxy reports. Sixty-nine...

  • Parental decision-making in congenital heart disease. Hoehn, K. Sarah; Wernovsky, Gil; Rychik, Jack; Zhi-yun Tian; Donaghue, Denise; Alderfer, Melissa A.; Gaynor, J. William; Kazak, Anne E.; Spray, Thomas L.; Nelson, Robert M. // Cardiology in the Young;Jun2004, Vol. 14 Issue 3, p309 

    Objective: To explore whether prenatal diagnosis of congenital heart disease is associated with lower levels of parental distress and greater satisfaction with decisions about cardiothoracic surgery when compared to postnatal diagnosis. Methodology: A combined quantitative-qualitative design was...

  • Parental perception of time and decision-making in neonatal research. Hoehn, K. S.; Nathan, A.; White, L. E.; Ittenbach, R. F.; Reynolds, W. W.; Gaynor, J. W.; Wernovsky, G.; Nicolson, S.; Nelson, R. M. // Journal of Perinatology;Jul2009, Vol. 29 Issue 7, p508 

    Objective:To assess the impact of time on parental decision-making for research participation for neonates with congenital heart disease.Study Design:Interviews were conducted with 37 parents of 19 neonates with congenital heart disease who were eligible for three different studies: genetic...

  • Preprocedure Prophylaxis Against Endocarditis Among United States Pediatric Cardiologists. Patel, Jasminkumar; Kupferman, Fernanda; Rapaport, Susana; Kern, Jeffrey // Pediatric Cardiology;Oct2014, Vol. 35 Issue 7, p1220 

    This study aimed to determine current practices regarding prophylaxis against infective endocarditis among pediatric cardiologists in the United States 5 years after publication of the most recent American Heart Association (AHA) recommendations. A descriptive, analytical, cross-sectional study...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics